{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:41Z","timestamp":1793136941382,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaad.2026.07.011","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:43:02Z","timestamp":1783600982000},"page":"1464-1466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of oral tofacitinib in patients with recalcitrant frontal fibrosing alopecia: A pilot study"],"prefix":"10.1016","volume":"95","author":[{"given":"Wipawan","family":"Vathananai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viyada","family":"Tamprateep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phanitchanat","family":"Phusuphitchayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8296-3251","authenticated-orcid":false,"given":"Chinmanat","family":"Lekhavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2026.07.011_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.19040","article-title":"Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing","volume":"183","author":"Del Duca","year":"2020","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.011_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12656","article-title":"Tofacitinib for the treatment of lichen planopilaris: a case series","volume":"31","author":"Yang","year":"2018","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2026.07.011_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","article-title":"A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring","volume":"13","author":"Samuel","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2026.07.011_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2023.07.037","article-title":"Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: a case series and review of the literature","volume":"40","author":"Dunn","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.011_bib5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaad.2024.01.060","article-title":"Topical tofacitinib for patients with lichen planopilaris and\/or frontal fibrosing alopecia","volume":"90","author":"Chen","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:28:44Z","timestamp":1793136524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226030768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0190962226030768"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.07.011","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of oral tofacitinib in patients with recalcitrant frontal fibrosing alopecia: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}